Yu Kenneth T, Wyer Peter C
Emergency Medicine Residency Program, New York Presbyterian Hospital, New York, NY, USA.
Ann Emerg Med. 2008 May;51(5):651-62, 662.e1-2. doi: 10.1016/j.annemergmed.2007.10.022. Epub 2008 Feb 13.
US regulatory authorities mandate delivery of antibiotics within 4 hours of arrival for patients being admitted to the hospital with community-acquired pneumonia. This evidence-based emergency medicine review examines the scientific evidence pertaining to this requirement.
We searched MEDLINE, EMBASE, the Cochrane Library, other databases, and bibliographies. We selected articles allowing comparison of inpatient or 30-day mortality among patients receiving early versus delayed antibiotics. We prospectively categorized studies according to whether they were retrospective or prospective and whether they adjusted for severity with the Pneumonia Severity Index. We evaluated the precision with which the interval to initiation of antibiotic therapy was defined and the compliance of retrospective studies with standard reporting criteria for chart reviews.
We identified 13 observational studies reporting comparative outcomes in patients receiving early versus delayed antibiotic initiation, of which 10 allowed calculation of our primary outcome. Of the 4 prospective studies, 1 allowed severity adjustment using the Pneumonia Severity Index score. Among the retrospective studies, definition of time to antibiotic therapy was frequently imprecisely defined, and compliance with standard reporting criteria for chart review was scanty in the subgroup lacking severity adjustment. Odds ratios (ORs) for mortality varied widely. One methodologically weak study reported a large benefit of early antibiotics (OR for mortality antibiotics <4 hours versus >4 hours 0.24; 95% confidence interval [CI] 0.08 to 0.71). The one study that used prospective enrollment and severity adjustment using the Pneumonia Severity Index observed a contrary result (adjusted OR for mortality, antibiotics <4 hours versus >4 hours 1.99; 95% CI 1.22 to 13.45). Results from studies reporting an 8-hour cutoff also varied in magnitude and direction of effect.
Evidence from observational studies fails to confirm decreased mortality with early administration of antibiotics in stable patients with community-acquired pneumonia. Although timely administration of antibiotics to patients with confirmed community-acquired pneumonia should be encouraged, an inflated sense of priority of the 4-hour time frame is not justified by the evidence.
美国监管机构规定,因社区获得性肺炎入院的患者需在入院后4小时内使用抗生素。本循证医学综述探讨了与该要求相关的科学证据。
我们检索了MEDLINE、EMBASE、Cochrane图书馆及其他数据库和参考文献。我们选择了能够比较早期使用抗生素与延迟使用抗生素的患者住院期间或30天死亡率的文章。我们根据研究是回顾性还是前瞻性以及是否使用肺炎严重程度指数对严重程度进行调整,对研究进行前瞻性分类。我们评估了抗生素治疗开始时间间隔的定义精度以及回顾性研究对图表审查标准报告标准的依从性。
我们确定了13项观察性研究,报告了早期使用抗生素与延迟使用抗生素患者的比较结果,其中10项研究可以计算我们的主要结局。在4项前瞻性研究中,1项研究允许使用肺炎严重程度指数评分进行严重程度调整。在回顾性研究中,抗生素治疗时间的定义往往不精确,在缺乏严重程度调整的亚组中,对图表审查标准报告标准的依从性很差。死亡率的优势比(OR)差异很大。一项方法学上较弱的研究报告了早期使用抗生素的巨大益处(抗生素使用时间<4小时与>4小时相比,死亡率的OR为0.24;95%置信区间[CI]为0.08至0.71)。一项使用前瞻性入组并使用肺炎严重程度指数进行严重程度调整的研究观察到了相反的结果(抗生素使用时间<4小时与>4小时相比,调整后的死亡率OR为1.99;95%CI为1.22至13.45)。报告8小时截止时间的研究结果在效应大小和方向上也有所不同。
观察性研究的证据未能证实早期使用抗生素可降低稳定的社区获得性肺炎患者的死亡率。虽然应鼓励对确诊的社区获得性肺炎患者及时使用抗生素,但证据并不支持将4小时时间框架的优先级过度提高。